All Information (Except Text) for H.R.269 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019116th Congress (2019-2020) |
Bill
Hide Overview| Sponsor: | Rep. Eshoo, Anna G. [D-CA-18] (Introduced 01/08/2019) |
|---|---|
| Committees: | House - Energy and Commerce; Homeland Security; Veterans' Affairs; Judiciary |
| Latest Action: | Senate - 01/10/2019 Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10. (All Actions) |
| Roll Call Votes: | There has been 1 roll call vote |
Tracker:
This bill has the status Passed House
Here are the steps for Status of Legislation:
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Subject — Policy Area:
- Health
- View subjects
There are 2 versions of this bill. View text
Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries
Titles (7)
Short Titles
Short Titles - House of Representatives
Short Titles as Passed House
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Short Titles as Passed House for portions of this bill
- Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
- Over-the-Counter Monograph User Fee Act of 2019
Short Titles as Introduced
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Short Titles as Introduced for portions of this bill
- Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
- Over-the-Counter Monograph User Fee Act of 2019
Official Titles
Official Titles - House of Representatives
Official Title as Introduced
To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.
Actions Overview (2)
| Date | Actions Overview |
|---|---|
| 01/08/2019 | Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 401 - 17 (Roll no. 13).(text: CR H237-262) |
| 01/08/2019 | Introduced in House |
All Actions (14)
| Date | Chamber | All Actions |
|---|---|---|
| 01/10/2019 | Senate | Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10. |
| 01/09/2019 | Senate | Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time. |
| 01/08/2019-7:01pm | House | Motion to reconsider laid on the table Agreed to without objection. |
| 01/08/2019-7:01pm | House | On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 401 - 17 (Roll no. 13). (text: CR H237-262) |
| 01/08/2019-6:30pm | House | Considered as unfinished business. (consideration: CR H275-276) |
| 01/08/2019-4:36pm | House | At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed. |
| 01/08/2019-4:14pm | House | DEBATE - The House proceeded with forty minutes of debate on H.R. 269. |
| 01/08/2019-4:14pm | House | Considered under suspension of the rules. (consideration: CR H237-266) |
| 01/08/2019-4:13pm | House | Mr. Pallone moved to suspend the rules and pass the bill. |
| 01/08/2019 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 01/08/2019 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 01/08/2019 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 01/08/2019 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 01/08/2019 | House | Introduced in House |
Cosponsors (7)
| Cosponsor | Date Cosponsored |
|---|---|
| Rep. Brooks, Susan W. [R-IN-5]* | 01/08/2019 |
| Rep. DeGette, Diana [D-CO-1]* | 01/08/2019 |
| Rep. Latta, Robert E. [R-OH-5]* | 01/08/2019 |
| Rep. Dingell, Debbie [D-MI-12]* | 01/08/2019 |
| Rep. Guthrie, Brett [R-KY-2]* | 01/08/2019 |
| Rep. Pallone, Frank, Jr. [D-NJ-6]* | 01/08/2019 |
| Rep. Walden, Greg [R-OR-2]* | 01/08/2019 |
Committees (4)
Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.
| Committee / Subcommittee | Date | Activity | Reports |
|---|---|---|---|
| House Energy and Commerce | 01/08/2019 | Referred to | |
| House Homeland Security | 01/08/2019 | Referred to | |
| House Veterans' Affairs | 01/08/2019 | Referred to | |
| House Judiciary | 01/08/2019 | Referred to |
Subjects (61)
Subject — Policy Area:
One Policy Area term, which best describes an entire measure, is assigned to every public bill or resolution.
- Administrative law and regulatory procedures
- Advanced technology and technological innovations
- Advisory bodies
- Aging
- Blood and blood diseases
- Border security and unlawful immigration
- Centers for Disease Control and Prevention (CDC)
- Chemical and biological weapons
- Child health
- Child safety and welfare
- Computer security and identity theft
- Congressional oversight
- Consumer affairs
- Disability and paralysis
- Disaster relief and insurance
- Drug safety, medical device, and laboratory regulation
- Emergency communications systems
- Emergency medical services and trauma care
- Emergency planning and evacuation
- Environmental health
- First responders and emergency personnel
- Food and Drug Administration (FDA)
- General health and health care finance matters
- Genetics
- Government employee pay, benefits, personnel management
- Government information and archives
- Government liability
- Hazardous wastes and toxic substances
- Health facilities and institutions
- Health information and medical records
- Health personnel
- Health programs administration and funding
- Health promotion and preventive care
- Health technology, devices, supplies
- Homeland security
- Hospital care
- Immunology and vaccination
- Infectious and parasitic diseases
- Infrastructure development
- Intelligence activities, surveillance, classified information
- Intergovernmental relations
- Judicial review and appeals
- Licensing and registrations
- Marketing and advertising
- Medical research
- Military medicine
- Minority health
- Musculoskeletal and skin diseases
- Natural disasters
- Performance measurement
- Prescription drugs
- Research and development
- Social work, volunteer service, charitable organizations
- State and local government operations
- Technology assessment
- Terrorism
- User charges and fees
- Veterinary medicine and animal diseases
- Women's health
- World health
Latest Summary (2)
Shown Here:
Passed House (01/08/2019)
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
This bill (1) reauthorizes, revises, and establishes several programs and entities relating to public-health emergency preparedness and response; and (2) addresses the approval process for over-the counter (OTC) drugs.
Among other programs, the bill reauthorizes through FY2023 and revises
- the Public Health Emergency Preparedness cooperative-agreement program administered by the Centers for Disease Control and Prevention (CDC),
- the Hospital Preparedness Program,
- the CDC situational-awareness and biosurveillance program,
- the Emergency System for Advance Registration of Volunteer Health Professionals,
- the National Disaster Medical System,
- the Volunteer Medical Reserve Corps,
- the National Advisory Committee on Children and Disasters,
- the Strategic National Stockpile, and
- the Biomedical Advanced Research and Development Authority.
In addition, the bill provides statutory authority for existing programs, including the CDC's Children's Preparedness Unit and the Public Health Emergency Medical Countermeasures Enterprise. The bill also establishes new programs and entities, including a trauma-center grant program to support military trauma teams.
The bill further modifies the approval process for OTC drugs by providing statutory authority for the Food and Drug Administration (FDA) to (1) regulate certain OTC drugs that are marketed without an approved new-drug application, and (2) issue administrative orders specifying the conditions under which an OTC drug may be deemed safe and effective and not subject to approval as a new drug. The FDA must assess and collect user fees for OTC drugs, including OTC-drug facility and OTC-drug order-request fees.